Discontinuing Specific Meds Linked to MS Relapse Risk : comp

In older patients with nonactive MS, there is a significant increased risk for relapse after discontinuing natalizumab and fingolimod, new research showed.

Related Keywords

France , Rennes , Bretagne , French , Anne Kerbrat , University Hospital Of Rennes , Department Of Neurology , University Hospital ,